6-喹啉-2-基-己-5-炔-1-醇 | 1046451-41-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 喹啉及其衍生物
• 中文名称: 6-喹啉-2-基-己-5-炔-1-醇
• 英文名称: 6-quinolin-2-yl-hex-5-yn-1-ol
• 英文别名: 6-Quinolin-2-ylhex-5-yn-1-ol
• CAS: 1046451-41-5
• 化学式: C₁₅H₁₅NO
• 分子量: 225.29
• InChiKey: CEWLGCXTQSXWGP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.9
• 重原子数：
  17
• 可旋转键数：
  4
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  33.1
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为产物：
  描述：

  2-氯喹啉 、 5-己炔-1-醇 在 palladium on activated charcoal copper(l) iodide 、 三乙胺 、 三苯基膦 作用下， 以 水 为溶剂， 反应 0.5h， 生成 6-喹啉-2-基-己-5-炔-1-醇
  参考文献：
  名称：

  Synthesis of 2-alkynylquinolines from 2-chloro and 2,4-dichloroquinoline via Pd/C-catalyzed coupling reaction in water

  摘要：

  The Pd/C-CuI-PPh3 catalyst system facilitated Sonogashira coupling of 2-chloroquinoline and 2,4-dichloroquinoline with terminal alkynes in water without generating any significant side products. A variety of 2-alkynylquinolines were prepared from 2-chloroquinoline in good to excellent yields and the 2,4-dichloroquinoline afforded monosubstituted product i.e., 2-alkynyl-4-chloro quinoline with high regioselectivity. The methodology was found to be effective for the alkynylation of 1-chloroisoquinoline and 3-methyl-2-chloroquinoline. (c) 2008 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.tet.2008.05.097

文献信息

• HETEROCYCLIC DERIVATIVES THAT ARE USED IN THE TREATMENT OF NEURODEGENERATIVE DISEASES
  申请人：Schmidt Fanny

  公开号：US20110118270A1

  公开（公告）日：2011-05-19

  The present invention relates to compounds of Formula (I) below, to their pharmaceutically acceptable salts and to their isomers or mixtures of isomers: HetAr—X—CHR 1 R 2 (I) in which: -HetAr represents a group chosen from: —X represents a linear, saturated or unsaturated, hydrocarbon-based chain comprising from 8 to 22 carbon atoms, optionally interrupted by an —NH— or —NH—CO— group, —R 1 represents a hydrogen atom or an —OH, —O(C 1 -C 6 )alkyl, —OCO((C 1 -C 6 )alkyl), —OSO 2 ((C 1 -C 6 )alkyl) or —OSO 3 H group, and —R 2 represents a hydrogen atom or a (C 2 -C 6 )alkynyl, (C 2 -C 6 )alkenyl or (C 3 -C 6 )cycloalkyl group. The present invention also relates to a process for preparing the compounds of Formula (I), and also to the use thereof, especially in the treatment of neurodegenerative diseases.

  本发明涉及以下化合物的化学式(I)，其药学上可接受的盐以及它们的异构体或异构体混合物：HetAr—X—CHR1R2(I)其中：-HetAr代表从中选择的一个基团：-X代表由8到22个碳原子组成的线性、饱和或不饱和的基于碳的链，可选地被一个—NH—或—NH—CO—基团中断，-R1代表氢原子或—OH，—O(C1-C6)烷基，—OCO((C1-C6)烷基)，—OSO2((C1-C6)烷基)或—OSO3H基团，-R2代表氢原子或(C2-C6)炔基，(C2-C6)烯基或(C3-C6)环烷基基团。本发明还涉及一种制备化学式(I)化合物的方法，以及其用途，特别是在治疗神经退行性疾病方面。
• US8445511B2
  申请人：——

  公开号：US8445511B2

  公开（公告）日：2013-05-21